Abstract
Efficacy and Safety of Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Patients Aged ≥75 Years with Acute Myeloid Leukemia (AML) in the Phase 3 AZA-AML-001 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have